PHILADELPHIA, PA — Franklin Biolabs, a contract research organization focused on genetic medicines, has named Dr. Vatsala Naageshwaran as its Chief Executive Officer. Founded by gene therapy pioneer Dr. James Wilson, Franklin Biolabs aims to advance innovative therapies for patients with rare and severe diseases.
Dr. Naageshwaran is a seasoned biopharmaceutical leader with over 20 years of experience in advancing cell and gene therapies. She has led cross-functional teams to enhance product and service offerings while generating significant revenue growth. Her prior leadership roles include Chief Business Officer at Absorption Systems, where she spearheaded global business strategies, and Vice President of Business Development for Cell and Gene Therapy at Pharmaron.
Dr. Wilson, Chairperson of Franklin Biolabs, emphasized the importance of her appointment, stating, “With her decades of experience building high-performing teams and directing results-driven operations, Vatsala is well equipped to lead Franklin Biolabs as it brings transformative therapies to more patients.”
Dr. Naageshwaran’s career began in biotech roles with Myriad Genetics and Astex Pharmaceuticals. Her track record includes earning FDA grants and overseeing award-winning research facilities. She has been recognized for her contributions to the industry, including nominations for prestigious business awards and publications in scientific journals.
Expressing her excitement about the new role, Dr. Naageshwaran said, “I am absolutely thrilled to join Franklin Biolabs and be a part of the groundbreaking work that Dr. Wilson and his team are doing at the forefront of gene therapy and healthcare innovation.”
Dr. Naageshwaran’s leadership marks a significant step forward for Franklin Biolabs as it continues its mission to develop groundbreaking treatments in genetic medicine.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.